| P50 | author | Thomas P Schaer | Q85154487 |
| P2093 | author name string | Alix K Berglund | |
| | Lauren V Schnabel | |
| | Jessica M Gilbertie | |
| | Julie M Long | |
| | Alicia G Schubert | |
| P2860 | cites work | Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future | Q26740490 |
| | Use of platelet lysate for bone regeneration - are we ready for clinical translation? | Q26765255 |
| | The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | Q26778884 |
| | Platelet-rich plasma in orthopedic therapy: a comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions | Q26825183 |
| | Gait Changes Vary among Horses with Naturally Occurring Osteoarthritis Following Intra-articular Administration of Autologous Platelet-Rich Plasma | Q27303631 |
| | Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival | Q28363133 |
| | Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro | Q28392792 |
| | Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis | Q33165680 |
| | Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives | Q33727388 |
| | Lubricin/proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis | Q33847985 |
| | Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharide | Q35669327 |
| | In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide. | Q36066372 |
| | The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries | Q36066594 |
| | Spectrophotometric quantitation of tissue culture cell number in any medium | Q71666150 |
| | Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 | Q72690586 |
| | Effects of hyaluronic acid on the morphology and proliferation of human chondrocytes in primary cell culture | Q73509388 |
| | Tendon healing in interleukin-4 and interleukin-6 knockout mice | Q81445709 |
| | Assessment of the catabolic effects of interleukin-1beta on proteoglycan metabolism in equine cartilage cocultured with synoviocytes | Q83893005 |
| | Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes | Q84800580 |
| | Safety and Efficacy of Autologous Intra-articular Platelet Lysates in Early and Intermediate Knee Osteoarthrosis in Humans: A Prospective Open-Label Study | Q85942377 |
| | Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy | Q87405733 |
| | Innate immune responses of equine monocytes cultured in equine platelet lysate | Q49715523 |
| | Comparison of Platelet-Rich Plasma, Stromal Vascular Fraction (SVF), or SVF with an Injectable PLGA Nanofiber Scaffold for the Treatment of Osteochondral Injury in Dogs | Q50067097 |
| | The matrix synthesis and anti-inflammatory effect of autologous leukocyte-poor platelet rich plasma in human cartilage explants | Q50127421 |
| | Natural assembly of platelet lysate-loaded nanocarriers into enriched 3D hydrogels for cartilage regeneration | Q50216222 |
| | Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. | Q51168653 |
| | Senescence and quiescence in adipose-derived stromal cells: Effects of human platelet lysate, fetal bovine serum and hypoxia. | Q51369153 |
| | Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. | Q53148322 |
| | Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons. | Q53319280 |
| | Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells. | Q54259193 |
| | Platelet-rich plasma: a milieu of bioactive factors. | Q54330963 |
| | Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis | Q56986258 |
| | Platelet Lysate Promotes in Vitro Proliferation of Equine Mesenchymal Stem Cells and Tenocytes | Q57946601 |
| | Shedding light in the controversial terminology for platelet-rich products: Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism | Q59289017 |
| | The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation | Q60632874 |
| | Interleukin-6: a growth factor stimulating collagen synthesis in human tendon | Q61532823 |
| | The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials | Q36258099 |
| | Distribution and processing of a disintegrin and metalloproteinase with thrombospondin motifs-4, aggrecan, versican, and hyaluronan in equine digital laminae | Q36503719 |
| | RNA Interference Mediated Interleukin-1β Silencing in Inflamed Chondrocytes Decreases Target and Downstream Catabolic Responses | Q36747491 |
| | Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice | Q36904978 |
| | The influence of environmental variables on platelet concentration in horse platelet-rich plasma | Q37064561 |
| | Hypoxia. HIF-mediated articular chondrocyte function: prospects for cartilage repair | Q37397668 |
| | Regenerative therapies for equine degenerative joint disease: a preliminary study | Q37496010 |
| | Platelet-Rich Plasma Injections for Advanced Knee Osteoarthritis: A Prospective, Randomized, Double-Blinded Clinical Trial | Q37649932 |
| | In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes | Q37899252 |
| | Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. | Q38162688 |
| | Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration | Q38166202 |
| | Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment | Q38167654 |
| | Considerations for the use of platelet-rich plasma in orthopedics | Q38206749 |
| | Intra-articular platelet-rich plasma for the treatment of osteoarthritis | Q38254074 |
| | Role of HIF-1α and HIF-2α in osteoarthritis | Q38305626 |
| | Hyaluronic Acid Versus Platelet-Rich Plasma | Q38381462 |
| | Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? | Q38631723 |
| | Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis | Q39225791 |
| | Harmful Effects of Leukocyte-Rich Platelet-Rich Plasma on Rabbit Tendon Stem Cells In Vitro | Q39762482 |
| | Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons | Q40144361 |
| | Characteristics of canine platelet-rich plasma prepared with five commercially available systems. | Q40605602 |
| | Proinflammatory and Anabolic Gene Expression Effects of Platelet-Rich Gel Supernatants on Equine Synovial Membrane Explants Challenged with Lipopolysaccharide | Q41067794 |
| | Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants | Q41978539 |
| | Isolation, propagation, and cryopreservation of equine articular chondrocytes | Q42457727 |
| | Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint | Q42488352 |
| | Comparison of three human platelet lysates used as supplements for in vitro expansion of corneal endothelium cells | Q42515633 |
| | Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients | Q42520334 |
| | Autologous Platelet-Rich Plasma Preparations: Influence of Nonsteroidal Anti-inflammatory Drugs on Platelet Function. | Q43200167 |
| | The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. | Q43455239 |
| | Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering | Q43883836 |
| | Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution | Q44713149 |
| | Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1. | Q44836816 |
| | Plasma and synovial fluid concentration of doxycycline following low-dose, low-frequency administration, and resultant inhibition of matrix metalloproteinase-13 from interleukin-stimulated equine synoviocytes. | Q45340654 |
| | Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: a comparison with articular chondrocytes | Q46460748 |
| | Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma | Q46865102 |
| | Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment | Q46891204 |
| | Protective effect of hyaluronic acid on interleukin-1-induced deregulation of beta1-integrin and insulin-like growth factor-I receptor signaling and collagen biosynthesis in cultured human chondrocytes. | Q46978875 |
| | Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study | Q47740580 |
| | Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors | Q47783595 |
| | The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy | Q47923503 |
| | Platelet lysate activates quiescent cell proliferation and reprogramming in human articular cartilage: Involvement of hypoxia inducible factor 1. | Q48157123 |
| | Platelet lysate enhances synovial fluid multipotential stromal cells functions: Implications for therapeutic use. | Q49339856 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 150 | |
| P577 | publication date | 2018-07-04 | |
| P1433 | published in | Frontiers in Veterinary Science | Q27726928 |
| P1476 | title | Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators | |
| P478 | volume | 5 | |